Godelieve J. de Bree

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Philip J. M. Brouwer, Tom G. Caniels, Karlijn van der Straten et al. · Science · 2020 · 1.3K citations · Full text

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

Willianne Hoepel, Hung‐Jen Chen, Chiara E. Geyer et al. · Science Translational Medicine · 2021 · 245 citations · Full text

Immunodeficiencies, Humoral Response, Immunology +21

Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection

Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse et al. · Cell · 2021 · 199 citations · Full text

Vaccination, Mucosal Vaccination, Cross-protection +12

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Philip J. M. Brouwer, Tom G. Caniels, Karlijn van der Straten et al. · 2020 · 153 citations · Full text

Vaccine Development, Non-rbd Epitopes, Vaccine Research +15

A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination

Rosanne W. Wieten, Emile F.F. Jonker, Ester M. M. van Leeuwen et al. · PLoS ONE · 2016 · 109 citations · Full text